
Business of Cannabis Europe
MGC Pharmaceuticals Releases CogniCann Phase II Clinical Trial Results
MGC Pharmaceuticals Ltd (‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development of

MGC Pharmaceuticals Ltd (‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development of

· MGC EXECUTES supply and distribution agreement with international pharmaceuticals company Sciensus Rare. · Sciensus Rare is an established international pharmaceutical services
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.